More on OVID

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-83.3% Growth)
- Ratings (7.8 Score)
- Holders

Upcoming Events

- Earnings (8/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Ovid Therapeutics (NQ:OVID)
Delayed: 2.27 -0.15 (6.2%)
Prev. Close $2.42  
Open$2.44 
52 Wk High$ 
52 Wk Low$ 
Day High$2.49 
Day Low$2.27 
P/E N/A  
EPS$ 
Volume15,348,113 


Jun 17, 2026 04:22 PM Form 4 Ovid Therapeutics Inc. For: Jun 15 Filed by: Greka Anna
Jun 17, 2026 04:20 PM Form 3 Ovid Therapeutics Inc. For: Jun 15 Filed by: Greka Anna
Jun 11, 2026 09:03 AM Form 8-K Ovid Therapeutics Inc. For: Jun 11
Jun 4, 2026 07:00 AM Ovid Therapeutics to Participate in Upcoming Investor Conferences
Jun 3, 2026 07:03 AM Form 8-K Ovid Therapeutics Inc. For: May 29
Jun 3, 2026 07:00 AM Ovid Therapeutics names Anna Greka to board of directors
Jun 3, 2026 07:00 AM Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
May 15, 2026 04:30 PM Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 11:58 AM Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
May 15, 2026 08:04 AM Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: Sirenia Capital Management LP
View All Articles

Entities mentioned with OVID

View All Entities